Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
5(45%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_4
1
9%
Ph not_applicable
2
18%
Ph phase_1
2
18%
Ph phase_2
1
9%

Phase Distribution

2

Early Stage

1

Mid Stage

1

Late Stage

Phase Distribution6 total trials
Phase 1Safety & dosage
2(33.3%)
Phase 2Efficacy & side effects
1(16.7%)
Phase 4Post-market surveillance
1(16.7%)
N/ANon-phased studies
2(33.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

5

trials recruiting

Total Trials

11

all time

Status Distribution
Active(7)
Completed(2)
Other(2)

Detailed Status

Recruiting3
Not yet recruiting2
Active, not recruiting2
Completed2
unknown2

Development Timeline

Analytics

Development Status

Total Trials
11
Active
5
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 12 (33.3%)
Phase 21 (16.7%)
Phase 41 (16.7%)
N/A2 (33.3%)

Trials by Status

not_yet_recruiting218%
active_not_recruiting218%
completed218%
recruiting327%
unknown218%

Recent Activity

Clinical Trials (11)

Drug Details

Intervention Type
DIAGNOSTIC TEST
Total Trials
11